Building a successful cross-linking practice
Surgeons from iLink Centers of Excellence offer pearls, from optimal scheduling to networking.
Teprotumumab: First FDA-approved treatment for TED
Treatment option offers positive outcome for patients diagnosed with disease.
Preservative-free latanoprost vs BAK-preserved latanoprost
Therapeutic has fewer adverse effects in patients with POAG, OHT.
Peptide therapeutics are being introduced into ophthalmology
New option a potential treatment for patients diagnosed with dry eye disease.
Understanding options for combination myopia management
Dual therapy may slow the progression of condition.
Expert sheds light on treating EBMD and recurrent erosions
Medical, surgical management can be important tools.
Lessons from the Togo Glaucoma Project
SLT shows promise as treatment for millions of Africans with glaucoma.
New approach to foveal holes: Light, sound, and nutraceuticals
Macular hole closure results from this novel treatment.
Pegcetacoplan injection is effective for managing geographic atrophy
Data demonstrate a reduction in the loss of retinal pigmented epithelial and photoreceptor cells.
How decreased cone densities may help detect and monitor MS
Study: AO retinal imaging has the potential to become a sensitive marker for disease.
Taking the long view of managing myopia
The number of cases continues to rise throughout the world
Game changer: Genetic testing shifts paradigm in assessing corneal dystrophies
Clinical judgment is not always sufficient to determine whether a patient has an inherited corneal disorder.
Cell therapy for corneal endothelial disease gains traction
Groundbreaking treatment for patients with bullous keratopathy approved in Japan.
Focusing on laser trabeculoplasty, the glaucoma workhorse
Debate continues over the best way to apply the treatment option.
